STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
OPNT OPIANT PHARMACEUTICALS INCORPORATED StockScouter® Report
4
StockScouter® Score
OPIANT PHARMACEUTICALS INCORPORATED, a micro cap growth company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
- Moving average analysis for OPNT suggests strong price movement over the medium term. Positive
Concerns
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
- Two or more executives, directors or major shareholders – including one high-level executive –sold a small number of shares recently. Very negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, growth stocks will be neutral, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
N/A
D
D
A